
News|Articles|May 1, 2011
First-time generic approval May 2011
Generic drug approved by FDA (through May 2011): Latanoprost
Advertisement
Latanoprost ophthalmic solution, 0.005% (eqiv. to Xalatan)
MYLAN
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
2
CGM prescribed by primary care lowers A1C and acute care use in diabetes patients
3
Could uveitis in patients with melanoma being treated with immune checkpoint inhibitors be a good thing?
4
A conversation with Dolores Malaspina, M.D., about the generational impact of Holocaust trauma on schizophrenia risk
5


























